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Bacillus anthracis, the bacterium that causes 
anthrax, is responsible for varying death rates among 
animal species. Difﬁ  culties in case detection, hazardous 
or inaccessible carcasses, and misdiagnosis hinder 
surveillance. Using case reports and a new serologic 
assay that enables multispecies comparisons, we 
examined exposure to and illness caused by B. anthracis 
in different species in the Serengeti ecosystem in Tanzania 
during 1996–2009 and the utility of serosurveillance. High 
seroprevalence among carnivores suggested regular 
nonfatal exposure. Seropositive wildebeest and buffalo 
showed that infection was not invariably fatal among 
herbivores, whereas absence of seropositivity in zebras 
and frequent detection of fatal cases indicated high 
susceptibility. Exposure patterns in dogs reﬂ  ected known 
patterns of endemicity and provided new information about 
anthrax in the ecosystem, which indicated the potential of 
dogs as indicator species. Serosurveillance is a valuable 
tool for monitoring and detecting anthrax and may shed 
light on mechanisms responsible for species-speciﬁ  c 
variability in exposure, susceptibility, and mortality rates.
A
nthrax, which is caused by the gram-positive, 
sporulating bacterium Bacillus anthracis, primarily 
affects herbivorous livestock and wildlife species, but 
also poses serious public health risks in many parts of the 
world. Carnivores may also become infected by ingesting 
contaminated carcasses, but disease-associated illness and 
death are rarer than in herbivores. Although the multihost 
nature of the pathogen presents epidemiologic challenges, 
heterogeneities in host range and infection outcome provide 
opportunities for disease surveillance, e.g., through the use 
of sentinel or indicator species to detect the pathogen and 
changes in its prevalence or incidence (1,2).
Despite the recognized value of serologic data for 
disease surveillance and epidemiologic investigations, 
serologic analysis has only rarely been used in studies 
of anthrax. One reason may be the perception that case 
detection is relatively straightforward: a syndrome of 
sudden death in herbivores is useful for presumptive 
diagnosis, and microscopic examination of blood smears 
provides a relatively simple conﬁ  rmatory test. However, 
in many environments in which anthrax is endemic, 
carcasses deteriorate rapidly, are hazardous, and may be 
inaccessible for sampling for laboratory conﬁ  rmation. 
The utility of carcasses for case detection depends on the 
likelihood of observation and subsequent reporting (3). In 
many parts of Africa, anthrax is typically documented only 
during large, dramatic outbreaks (4–7). In remote areas 
or during small outbreaks, carcasses often go undetected 
and, even when detected, may provide only an incomplete 
picture of spatiotemporal patterns of infection. In humans, 
many anthrax cases are not reﬂ  ected in hospital records. 
Underreporting is particularly likely for pulmonary and 
gastrointestinal anthrax, which have high case-fatality rates 
and pose diagnostic challenges (8,9), leading to a lack of 
appreciation of the true scale of the disease in anthrax-
endemic regions.
Another explanation for the lack of serologic studies 
may be the perception that because sudden death is a 
distinctive feature of anthrax in herbivores, most infected 
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animals will not survive to produce an antibody response. 
However, susceptibility varies widely among species, and 
even within a susceptible species, seropositive animals have 
been detected, e.g., in cattle in the United Kingdom (10) and 
bison (Bison bison) species in North America (11). Turnbull 
et al. documented serologic evidence of infection in Etosha 
lions (Panthera leo) and suggested that lions can serve as 
an indicator species of anthrax in disease-endemic areas 
because of their territorial behavior (10,12). The potential 
of using serologic analysis for comparative studies has also 
been limited because, up until now, serologic assays for 
detecting antibodies to anthrax in a variety of species have 
not been widely available, even in research settings.
The constraints of anthrax surveillance, particularly 
in tropical areas, highlight the need to identify alternative 
approaches to overcome these difﬁ   culties. We present 
results of analyses of data obtained opportunistically in the 
Serengeti ecosystem in Tanzania to explore the value of 
serologic analysis for providing information about anthrax 
infection and exposure patterns in large, remote, and complex 
ecosystems. Using seroprevalence data obtained with 1 assay 
for a range of species, we also investigate within-species 
and between-species variations in exposure and survival 
to evaluate which species may be useful as indicators of 
anthrax for surveillance purposes, speciﬁ  cally to identify 
high-risk areas for human and livestock populations.
Materials and Methods
Study Area
The study area in the Serengeti ecologic region in 
northwestern Tanzania comprised wildlife-protected 
areas, including the Serengeti National Park (SNP) and 
adjacent game reserves (Maswa, Ikorongo, and Grumeti). 
Study sites also included multiethnic, agropastoralist 
communities west of SNP and Ngorongoro District east of 
SNP, a multiple land use game controlled area inhabited 
by low-density Maasai and Sonjo communities that had 
production systems based on traditional pastoralism 
and limited cultivation. Ngorongoro district is divided 
into the Loliondo Game Control Area in the north and 
the Ngorongoro Conservation Area (NCA) in the south 
(Figure 1).
Disease Monitoring Operations
Disease detection in wildlife was based upon passive 
surveillance operations in the study area during 1996–2009. 
Sightings of carcasses were reported through a network of 
veterinarians from Tanzania National Parks (TANAPA) 
and Tanzania Wildlife Research Institute (TAWIRI), 
rangers, scientists, and tour operators.
Passive surveillance data from outside SNP were 
available through veterinary ofﬁ  ce  records  (government 
ofﬁ  ces, TAWIRI, TANAPA, and NCA Authority). Human 
anthrax cases were compiled from records of government 
and mission hospitals in the study area for 1995–2008. 
Further information about human anthrax cases was 
obtained through key informants in villages affected by a 
major anthrax outbreak in 2006, and data on the age, sex, 
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Figure 1. Anthrax cases and exposure to anthrax in the study 
area, Tanzania. Blue areas indicate lakes. A) Location of wildlife 
carcasses during anthrax outbreaks. Shaded areas indicate 
regions where human anthrax cases were reported during 1995–
2008. Exact locations of carcasses obtained during the Sopa 1998 
outbreak were not available; open circles indicate area where 549 
probable cases and 67 suspected cases were detected. For the 
Seronera 2003 outbreak, locations of cases were randomized 
within a 10-km radius of the outbreak area because exact locations 
of carcasses were not available. B) Seroprevalence in domestic 
dog populations from sampled villages. Sample size is indicated 
by the radii of the pie charts. Green border indicates Serengeti 
ecosystem. LGCA, Loliondo Game Control Area; SNP, Serengeti 
National Park; NCA, Ngorongoro Conservation Area.Serologic Surveillance of Anthrax, Tanzania
clinical presentation, and outcome of infection of affected 
family members was obtained from heads of affected 
households. No human cases were conﬁ  rmed by laboratory 
diagnostic tests.
Case Deﬁ  nitions
Because of the relatively low proportion of suspected 
cases from which diagnostic samples were obtained, cases 
were classiﬁ  ed as suspected for carcasses found that had 
no obvious cause of death, and probable for carcasses that 
showed evidence of bloody discharge from the anus, vulva, 
nostrils, mouth, eyes, or ears and incomplete rigor mortis. 
Microscopic examination of methylene blue–stained blood 
smears was conducted for some carcasses. Smears positive 
by microscopy (detection of encapsulated bacilli) were 
combined with probable cases (27% of probable cases were 
conﬁ  rmed by microscopy) for analyses. No samples were 
conﬁ   rmed by bacterial culture and isolation because of 
lack of facilities locally. Because of abundant scavengers 
in the ecosystem and logistical challenges of surveillance 
over such a large and remote area, many cases will go 
undetected on the basis of our deﬁ  nitions. Speciﬁ  cally, our 
deﬁ  nitions comprised only intact or partially scavenged 
carcasses; this second group also included carcasses 
obtained during major reported outbreaks. Carcasses that 
were too decomposed or scavenged to enable classiﬁ  cation 
were not included in either group.
Serum Samples
Serum samples were obtained opportunistically as part 
of long-term epidemiologic and ecologic studies. Samples 
were obtained from 3 groups. The ﬁ  rst group comprised 
wild carnivore species, including 263 Serengeti and 23 
Ngorongoro Crater lions obtained during 1985–2007 and 
53 Serengeti spotted hyenas (Crocuta crocuta) obtained 
during 1998–2007. The second group comprised Serengeti 
and Ngorongoro Crater ungulate species (28 and 21 buffalo 
[Syncerus caffer], 36 and 23 wildebeest [Connochaetes 
taurinus], and 74 and 11 zebra [Equus burchellii], 
respectively) obtained during 1998–2007. The third group 
comprised domestic dog (Canis familiaris) populations 
living adjacent to protected areas (4 villages in Loliondo 
Division, 13 in NCA, and 7 from areas west of SNP), which 
included 169 random samples obtained as part of other 
epidemiologic surveys and 53 samples linked to a major 
anthrax outbreak in pastoralist areas in 2006.
Serologic Assays
The QuickELISA Anthrax-PA Kit immunoassay 
(Immunetics Inc., Boston, MA, USA) was used to detect 
antibodies against protective antigen (PA) of B. anthracis 
in serum samples (13). The assay detects immunoglobulins 
in a subtype-independent and species-independent manner. 
The assay was conducted according to the manufacturer’s 
instructions. Brieﬂ   y, serum (10 μL) was incubated 
with a mixture of 2 recombinant PA (rPA) conjugates: 
streptavidin-rPA and horseradish peroxidase–rPA. PA-
speciﬁ  c, multivalent antibodies formed ternary complexes 
in which streptavidin-rPA and horseradish peroxidase–
rPA were bound to different antigen-combining sites on 1 
antibody molecule. Complexes were bound to the biotin-
coated microplates by using streptavidin conjugate and 
detected by using horseradish peroxidase conjugate.
Bound antibodies against PA were detected by using a 
chromogenic peroxidase substrate (tetramethylbenzidine). 
The color development reaction was stopped by addition 
of 2N sulfuric acid. Absorbance at 450 nm, corrected by 
a 620–650 nm background subtraction, was measured by 
using an ELISA microplate reader. Interpretation was based 
on comparison of absorbance for the sample with an assay-
deﬁ  ned cutoff value. The QuickELISA Anthrax-PA kit was 
conﬁ  gured to detect ≈300 ng/mL of PA-speciﬁ  c antibody 
at the cutoff value. The assay cutoff value was deﬁ  ned as 
the mean net absorbance at 450 nm plus 0.1 of the negative 
control (provided in the kit); the targeted cutoff range was 
0.11–0.25.
Data Analysis
A generalized linear modeling framework was used 
to investigate seroprevalence patterns in domestic dogs 
and wildlife with a binary outcome (seronegative or 
seropositive) and binomial error structure. Three models 
were constructed. First, we tested for overall species-
speciﬁ  c differences in seroprevalence among lion, hyena, 
buffalo, wildebeest, and zebra populations in SNP and 
Ngorongoro Crater. Second, we tested for differences in 
seroprevalence in lion and hyena populations between 
years. Third, we analyzed seroprevalence patterns in 
domestic dogs in relation to their age and geographic 
location; village was modeled as a random effect by using 
a generalized linear mixed model.
Results
Case-Detection Patterns
Wildlife Cases
Potential anthrax cases, i.e., suspected and probable 
cases, were detected in a wide range of wildlife species, 
including wildebeest, buffalo, impala (Aepyceros 
melampus), giraffe (Giraffa camelopardalis), Thomson’s 
gazelle (Eudorcas thomsonii), and Grant’s gazelle (Nanger 
granti), hippopotamus (Hippopotamus amphibius), 
elephant (Loxodonta africana), and topi (Damaliscus 
korrigum jimela) (Table 1). The anthrax-attributed deaths of 
1 cheetah (Acinonyx jubatus) and 1 serval cat (Leptailurus 
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serval) during an outbreak in 1998 were the only carnivore 
cases reported during the study.
Cases were detected every year in NCA and SNP. 
However, major reported outbreaks were limited in time 
and space (Figure 1, panel A). Species affected and 
extent of outbreaks varied. Impalas were predominantly 
affected during 2 outbreaks (in southcentral Serengeti 
in late January–early February 1998 [14] and in central 
Serengeti in January 2003). Wildebeest and zebras were 
mostly affected during an outbreak east of SNP in early 
2006. Buffalo were most recently affected southwest of 
SNP in October 2009. Small numbers of zebra deaths were 
recorded regularly throughout the study period, in addition 
to the 2006 outbreak.
Livestock Cases
During 1996–1999, several large outbreaks (>500 
deaths) were documented in livestock (goats, sheep, 
and cattle) east of SNP. Suspected cases were reported 
regularly in some localities in apparently localized 
disease-endemic foci (i.e., Olbalbal, Oiti, and Olduvai; 
Figure 1, panel B). Small-scale vaccinations in the local 
vicinity were generally performed in response to these 
outbreaks. No livestock cases were reported from 2000 
until the end of 2003, during which time considerable 
livestock vaccination was conducted. Livestock cases 
have been reported since 2004, and many livestock 
carcasses were obtained during the 2006 wildlife outbreak 
(Figure 2). However, local Maasai communities attributed 
these deaths to starvation, and diagnostic material was not 
available for conﬁ  rmation.
Human Cases
Hospital records of anthrax-infected humans were 
typiﬁ  ed by sporadic reports of nonfatal cutaneous anthrax 
from a few localities (Figure 1, panel A; Figure 2). However, 
small-scale household questionnaire surveys conducted in 
villages where livestock and wildlife anthrax outbreaks 
had occurred indicated several cases in persons who had 
eaten affected livestock carcasses (50% case-fatality rate, 
4 deaths and 8 cases in 7,538 persons). Clinical signs 
included diarrhea and swollen abdomen (consistent with 
ascites), which are features of gastrointestinal anthrax.
Serologic Patterns
Wildlife
Seroprevalence patterns of sampled wildlife varied 
widely and showed differences among species and 
populations (Figure 3). Overall seroprevalence was lower 
in wildlife populations in Ngorongoro than in Serengeti 
(p<0.001). Seroprevalence was consistently high in 
wild carnivores (90% and 57% overall seropositivity in 
Serengeti and Ngorongoro Crater lions, respectively, and 
87% seropositivity in Serengeti spotted hyenas) and did 
not show any signiﬁ   cant year-to-year variation, e.g., in 
years of known outbreaks (p>0.05). Age seroprevalence 
in Serengeti lions indicated a high frequency of infection, 
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Table 1. Potential anthrax cases detected in Serengeti wildlife species, Tanzania, 1996–2009 
Common name  Species
No. cases
Suspected Probable
Baboon Papio anubis 01
Black rhinoceros Diceros bicornis 10
Buffalo Syncerus caffer 20 85
Bushbuck Tragelaphus scriptus 10
Cheetah Acinonyx jubatus 01
Duiker Sylvicapra grimmia 01
Eland Taurotragus oryx 01 *
Elephant Loxodonta africana 24 7
Grant’s gazelle Nanger granti 23
Giraffe Giraffa camelopardalis 14 8
Hartebeest Alcelaphus buselaphus 01
Hippopotamus Hippopotamus amphibious 32 14
Impala Aepyceros melampus 35 659
Ostrich Struthio camelus 01
Serval Leptailurus serval 01
Thomson’s gazelle Eudorcas thomsonii 75
Topi Damaliscus korrigum jimela 04
Vulture Gyps africanus 02
Warthog Phacochoerus africanus 02
Waterbuck Kobus ellipsiprymnus defassa 11
Wildebeest Connochaetes taurinus 112 60
Zebra Equus burchellii 34 83
*Outbreak reported but individual case counts not available.Serologic Surveillance of Anthrax, Tanzania
seroconversion at a young age, and seropositive animals in 
all age groups (Figure 4, panel A). Seroprevalence was lower 
among herbivorous species (46% and 14% seropositivity in 
Serengeti and Ngorongoro Crater buffalo and 19% and 4% 
in Serengeti and Ngorongoro Crater wildebeest); no zebras 
were found to be seropositive despite relatively extensive 
sampling efforts (Figure 3).
Domestic Dogs
Seroprevalence patterns in domestic dog populations 
showed marked regional differences (Figure 1, panel 
B). Low seroprevalence was observed in agropastoralist 
western communities, and high and spatially variable 
seroprevalence was observed in pastoralist eastern 
communities (p<0.001) (Figure 1, panel B; Table 2). 
More speciﬁ   cally, high seroprevalence was recorded in 
dogs in pastoralist areas where livestock cases had been 
regularly reported (e.g., Olbalbal, Oiti, and Olduvai areas). 
High seroprevalence was also observed in domestic dogs 
sampled 6 weeks after the outbreak was detected in zebras 
and wildebeest in Ngorongoro in early 2006 (Figure 
4, panel B), and changes in mean antibody levels in 
domestic dogs sampled before and after the outbreak also 
reﬂ  ected recent exposure (Figure 2). Most dogs sampled 
in western areas of the Serengeti were seronegative, which 
is consistent with an absence of reports of anthrax cases in 
either the veterinary ofﬁ  ce or hospital records. However, 
seropositive dogs were detected in 1 village, Gibeshi, 
where anthrax had not been previously recorded (Figure 
1, panel B). Age seroprevalence patterns of dogs sampled 
in 1999 indicated seropositivity only in dogs >1 year of 
age, which is consistent with exposure occurring in 1997 or 
1998 (Figure 4, panel B).
Discussion
We report wide variation in patterns of exposure to 
anthrax and deaths among wild and domestic animal species 
and populations of the Serengeti ecosystem. Serologic 
data also highlight the potential value of domestic dogs as 
indicator species for identifying high-risk areas of infection 
for livestock and human populations.
The QuickELISA Anthrax-PA kit was a convenient 
method for assessing seroprevalence in the multiple species 
examined in this study. The assay does not rely on species-
speciﬁ  c or protein A/G conjugates to detect anthrax-speciﬁ  c 
antibodies and thus can detect any multivalent antibody in a 
sample. Previous studies that examined antibodies against 
anthrax in wildlife required unique conjugates speciﬁ  c for 
each species studied, which necessarily limited the number 
of species that could be examined (10). In our study, 
antibodies were measured in 6 species by using 1 assay. 
Thus, relative amounts of antibody present in each sample 
could be directly compared.
Lack of obvious clinical signs before death, 
inaccessibility of remote locations, decomposition, and 
hazardous carcasses all affect the quality of anthrax 
surveillance based on case detection. Despite concerted 
efforts to obtain samples from suspected cases, we 
recovered little diagnostic material for conﬁ  rmation. 
However, more probable cases were identiﬁ  ed on the basis 
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Figure 2. Anthrax case detection in wildlife, livestock, and human populations in the Serengeti ecosystem, Tanzania, 1996–2009. Probable 
(black bars) and suspected (white bars) wildlife cases (as deﬁ  ned in the Materials and Methods) are shown. Black circles indicate hospital 
records of anthrax scaled according to the number of cases, and rectangles indicate when cases in livestock were reported (quality of the 
data for livestock cases was too poor to quantify). Domestic dogs were sampled in villages near wildlife cases detected in 2006. Error bars 
indicate mean antibody responses and 95% conﬁ  dence intervals at the time of sampling; sample sizes are indicated. *During the 1998 
outbreak, 549 probable cases and 67 additional suspected cases were detected. OD, optical density.RESEARCH
of the appearance of carcasses. Laboratory results may not 
be conclusive even when diagnostic material is obtained. 
For example, when multiple blood slides were prepared 
from 1 buffalo carcass and tested blindly, the results were 
not consistently positive (only 2 of 6 slides were positive). 
Some outbreaks are likely to be missed even when probable 
case detection is used. This suggestion was conﬁ  rmed by 
using serosurveillance data; in some agropastoralist areas 
where anthrax had not been reported, serologic analysis of 
domestic dogs indicated that the disease had been present.
In contrast to sampling of suspected carcasses, 
serosurveillance of living animals poses no risk for anthrax 
infection and therefore offers an opportunity for gaining a 
better understanding of anthrax epidemiology, particularly 
in relation to patterns of infection and risk factors for 
exposure, susceptibility, and death. Our serologic data 
highlight differences between species in exposure and 
death, which may be explained by behavior and ecology. 
However, we caution that although our study suggests 
great potential for the use of this assay for multiple 
species comparisons, validation of serologic responses 
across a range of vaccinated species (possibly using zoo 
collections) would provide more deﬁ  nitive veriﬁ  cation of 
this proposition and should be prioritized.
Low mortality rates, combined with high seroprevalence 
rates (always >50% and approaching 90% in Serengeti 
populations), suggests that wild carnivores are regularly 
exposed to anthrax without apparent deaths. Although high 
mortality rates were reported for Kruger lions after periods 
of low anthrax incidence (4,10), high seroprevalence rates 
and low mortality rates are more commonly observed, 
which suggests a protective immune response presumably 
associated with more frequent exposure (4,10). Lions and 
hyenas may be exposed through consumption of infected 
prey, but domestic dogs may also be exposed when they 
scavenge infected carcasses (wildlife and livestock). Low 
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Figure 4. Anthrax seroprevalence patterns in carnivores, by age, 
Tanzania, 1996–2009. Lions (A) in Serengeti and domestic dogs 
(B) in agropastoralist regions where no outbreaks were detected 
(black line), in pastoralist regions where repeated outbreaks were 
detected (red line), and in an agropastoralist village where no 
outbreaks were reported but serologic surveys indicated previous 
exposure (blue line). Error bars indicate 95% conﬁ  dence intervals 
for age seroprevalence in lions and dogs, but are juxtaposed 
for dogs to improve readability. Sample sizes used to calculate 
seroprevalences are indicated.
Figure 3. Seroprevalence of anthrax in sampled wildlife populations 
from Serengeti National Park (white bars) and Ngorongoro Crater 
(gray bars), Tanzania, 1996–2009. Sample sizes used to calculate 
seroprevalence are indicated above the bars. Hyenas were not 
sampled in Ngorongoro Crater. Seropositive zebras were not 
detected. Error bars indicate 95% conﬁ  dence intervals based on a 
binomial distribution of the sample size and the seropositivity range 
that can be expected.Serologic Surveillance of Anthrax, Tanzania
seroprevalence rates and high mortality rates have been 
reported for cheetahs (15,16). These rates are consistent 
with the fact that cheetahs do not scavenge, and solitary 
hunting exposes them to fewer carcasses than group-
hunting lions and hyenas. Although data from this study 
are limited, detection of probable anthrax cases in cheetah 
and serval is consistent with a higher susceptibility in these 
carnivore species.
Relatively lower seroprevalence rates and higher 
mortality rates for ungulates than for carnivores suggest 
less routine exposure, higher susceptibility, or both. Major 
differences in herbivore susceptibility are inferred from 
the wide variation in seroprevalence detected in species 
sharing the same grazing areas, and thus probable exposure 
patterns. Zebras appear to be highly susceptible; however, 
buffalo and wildebeest can clearly survive infection. 
Seroprevalence in buffalo was high (≈50%) compared with 
previous reports for herbivores (≈7%) (10,17). Comparing 
seroprevalence in more species would enable assessment 
of relative roles of exposure versus susceptibility in 
explaining variable species mortality patterns characteristic 
for anthrax.
The reported species differences have potential 
implications for serosurveillance. Among wildlife, 
carnivores are likely to be the most sensitive indicators 
of whether infection is present in an area, acting as 
bioaccumulators of infection through consumption of 
infected carcasses (18). However, because lions and 
hyenas seroconvert at a relatively young age, temporal 
patterns of exposure from age seroprevalence data are 
difﬁ  cult to detect. Furthermore, hyenas are highly mobile 
in the Serengeti ecosystem (19), which reduces their utility 
for identifying speciﬁ   c high-risk areas. However, more 
detailed investigations of titer levels in relation to timing 
and location of anthrax outbreaks, including longitudinal 
studies of serial titers from known animals, could shed light 
on immunologic responses and enable more information to 
be obtained from serologic data.
These data suggest a possible utility of serosurveillance 
in buffalo, whose potential as indicator species has not 
been explored. Because ≈50% of Serengeti buffalo are 
seropositive for anthrax, these populations appear to 
provide a relatively sensitive indicator of the presence and 
prevalence of anthrax infection, e.g., major differences 
between populations in SNP and Ngorongoro Crater. 
Although serologic analysis of wildebeest detected these 
differences, seroprevalence in wildebeest was lower 
overall, and the wide-ranging migratory movements of the 
Serengeti herds limit the utility of these data for detecting 
spatial patterns. In comparison, buffalo herds range over 
relatively restricted areas, and serologic data can pinpoint 
high-risk areas. In many protected areas of Africa, buffalo 
are already routinely sampled for surveillance of diseases, 
such as rinderpest, bovine tuberculosis, and foot-and-mouth 
disease. We suggest that in areas where buffalo surveillance 
is ongoing, there is added value in using serum samples for 
monitoring anthrax exposure patterns. Serologic analysis 
of buffalo and analysis of environmental risk factors could 
also assist wildlife management strategies, e.g., risks 
associated with reintroductions of rhinoceros in different 
areas of the Serengeti, and identify priority areas for 
enhanced risk-based surveillance.
Domestic dogs have high potential value as indicators 
of human and livestock diseases (1,18). They are regularly 
exposed to a wide range of infections in disease-endemic 
areas; they are abundant and widely distributed, especially in 
developing countries; they are generally accessible for safe 
handling and sampling; they can be sampled at young ages, 
which enables reasonably accurate timing of outbreaks; and 
they live in close association with humans and livestock, 
which makes them good indicators of risk. In addition, 
vaccination campaigns present a cost-effective opportunity 
for obtaining large numbers of domestic dog samples (18). 
Consistent with these expectations, we have demonstrated 
that dogs in the Serengeti can be useful indicators of anthrax. 
They can be used to detect infection in an area, even 
when anthrax is not identiﬁ  ed in other species; they reﬂ  ect 
differences in infection prevalence in different areas; they 
can provide information about the timing of outbreaks (we 
observed variation in exposure with age) (Table 2); and they 
serve as an indicator of livestock and human disease risk 
and provide a basis for risk-based surveillance and targeted 
implementation of prevention measures (e.g., livestock 
vaccination or public health campaigns).
In conclusion, we demonstrated that serologic 
investigations of wildlife and domestic animals can 
provide valuable information about patterns of anthrax 
transmission and for identifying areas for risk-based 
surveillance. Serologic approaches also enable retrospective 
identiﬁ   cation of infected areas and timing of outbreaks 
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Table 2. Multivariate generalized linear mixed model analysis of risk factors for anthrax seropositivity in dogs, Tanzania, 1996–2009* 
Predictor Unit Estimate SE z score  p value  OR (95% CI) 
Intercept  6.224  1.275  4.881  <0.001 NA
Age Months 0.043 0.011 3.956  <0.001  1.044 (1.022–1.066) 
Area West Referent  Referent  Referent  Referent  1
Loliondo 4.178 1.696 2.463 0.014  65.21 (2.347–1,811.000) 
NCA 4.511 1.364 3.308  <0.001  90.97 (6.283–1,317.000) 
*OR, odds ratio; CI, confidence interval; NA, not applicable; NCA, Ngorongoro Conservation Area. RESEARCH
where case surveillance is limited because of remoteness 
of an area, poor reporting of cases to local or central 
authorities, misdiagnosis, and difﬁ   culties in performing 
conﬁ  rmatory laboratory diagnostic tests. Further research 
may enable more effective use of serologic data if insights 
can be gained into how antibody levels relate to timing and 
degree of exposure.
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